Pulse Biosciences, Inc.
PLSE
Kedudukan dalam Saham
#4283
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Harga Saham
$51.39
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$3.67B
Perubahan (1 hari)
1.09%
Perubahan (1 tahun)
197.94%
Negara
US
Perdagangan Pulse Biosciences, Inc. (PLSE)
Kategori
Healthcare
Nisbah P/B bagi Pulse Biosciences, Inc. (PLSE)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Pulse Biosciences, Inc., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Pulse Biosciences, Inc. dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | ||
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| 8.1997 | - |
US
|
|
| 1.7417 | - |
FR
|
|
| - | - |
JP
|
|
| 2.1258 | - |
US
|
|
| - | - |
CH
|
